John Sperzel is the president and CEO of T2 Biosystems As a healthcare executive, he has built and led high-performance teams at all levels around the world, and acquired companies in the United States, Europe, Asia and Latin America. Following his heart transplant in 2017, Sperzel returned to his role as a public company CEO and continues to pursue his lifelong passion to advance life-saving technologies.
Chief Executive’s June survey of 278 U.S. CEOs shows leading confidence indicator now at 5.5/10, the lowest reading in nearly a decade. Majority forecasts worsening conditions in the year ahead, though not a recession.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.